00000nam 2200000zi 4500 9.921571 CaOODSP 20230515120842 m o d f cr |n||||||||| 230406e20211110onc ob f000 0 eng d 9780660406923 CaOODSP eng rda CaOODSP n-cn--- H139-30/2021E-PDF Guide to distributing drugs intended for the Canadian market for consumption or use outside Canada (GUI-0145). Ottawa, ON : Health Canada = Santé Canada, November 10, 2021. ©2021 1 online resource (14 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Guide sur la distribution des médicaments destinés au marché canadien pour consommation ou usage à l’extérieur du Canada (GUI-0145). Includes bibliographical references (pages 13-14). "This guidance document sets out Health Canada’s interpretation of the requirements in sections C.01.014.8, C.10.004 and C.01.014.13 to C.01.014.14 of the FDR. These sections prohibit the holder of a DEL from distributing drugs intended for the Canadian market for consumption or use outside Canada unless the licensee has reasonable grounds to believe that doing so would not cause or worsen a drug shortage. The sections were implemented to safeguard the Canadian drug supply and help ensure that the people of Canada have continuous access to the drugs they need to maintain their health"--Purpose, page 5. Drugs Law and legislation Canada. Pharmaceutical policy Canada. Canada. Health Canada, issuing body. Guide sur la distribution des médicaments destinés au marché canadien pour consommation ou usage à l’extérieur du Canada (GUI-0145). (CaOODSP)9.921572 PDF 731 KB https://publications.gc.ca/collections/collection_2023/sc-hc/H139-30-2021-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/drugs-health-products/guide-distributing-canadian-market-consumption-outside-canada.html 210404